Inclusion of E-cigarette Devices in 2024 Inflation Calculation

Regulations by 2FIRSTS.ai
Dec.13.2023
Inclusion of E-cigarette Devices in 2024 Inflation Calculation
Indonesia's Central Statistics Agency announces inclusion of e-cigarette devices in inflation calculation due to significant consumption.

According to an article published by the Indonesian media outlet REPUBLICA on December 12th, the Central Bureau of Statistics in Indonesia (BPS) announced that e-cigarette devices will be included in the inflation calculation for the year 2024. This decision has been made due to the significant proportion of the population that is consuming these products.

 

Pudji Ismartini, the Deputy Director of Distribution Statistics at the Indonesian Central Statistics Agency (BPS), said, "Changes in societal consumption patterns have resulted in the inclusion of new goods in the calculation of inflation.

 

According to the baseline year set by the 2022 cost of living survey, the city of Ismatini has added a list of 89 new products, including masks, e-cigarette devices, and e-cigarette liquid.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai
UK government letter agrees nicotine pouches are lower risk than smoking and a harm reduction tool
UK government letter agrees nicotine pouches are lower risk than smoking and a harm reduction tool
In correspondence with 20isPlenty campaigners, the government agreed nicotine pouches are likely to pose lower health risks than smoking and confirmed they are a harm reduction tool, while warning about their high nicotine content, fast absorption and potential to be flavoured.
Jan.06 by 2FIRSTS.ai
Make Your Brand Understood by the People Who Matter
Make Your Brand Understood by the People Who Matter
Feb.02
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
Six Years of Data Show FDA Clearing PMTA Backlog
Six Years of Data Show FDA Clearing PMTA Backlog
FDA data from FY2020 to FY2025 show how the PMTA system for e-cigarette products evolved after an early surge of submissions created prolonged front-end delays. Millions of applications accumulated at the Acceptance stage before entering substantive review. Since 2023, the number of applications pending acceptance has declined sharply, and industry participants report shorter initial decision timelines in late 2025.
Feb.06
Product | Compatible with 3ml/2ml Pods and Up to 45W Output: RELX Launches a New Open-System E-Cigarette on Its Indonesia Website
Product | Compatible with 3ml/2ml Pods and Up to 45W Output: RELX Launches a New Open-System E-Cigarette on Its Indonesia Website
RELX has launched the open-system RELX Prime Pro on its Indonesia website and has also rolled it out across multiple local e-commerce channels. According to publicly available product pages, the device is rated at up to 45W, features a 1350mAh battery, and is compatible with 3ml and 2ml pod capacities.
Dec.30 by 2FIRSTS.ai